- Dosage: Amoxicillin 400mg + Clavulanic Acid 57mg
- Packaging: 10 tablets/blister*10/box
- Shelf Life: 36months
Package:
Product Description
Amoxicillin Clavulanate 400/57mg Chewable Tablets: What the Published Guidance Says
A broad portfolio spanning the WHO Access and Watch groups, supplied with the documentation that stewardship programmes and national tenders require.
Buyers usually settle three things before ordering Amoxicillin Clavulanate 400/57mg Chewable Tablets: the pharmacopoeial monograph, the pack configuration, and the documents the destination authority will ask for.
- Access group — the empirical workhorses The WHO AWaRe classification places amoxicillin, amoxicillin + clavulanic acid, ampicillin, clindamycin, gentamicin, metronidazole, chloramphenicol and doxycycline in the Access group. These are the medicines expected to be available in every functioning health system. WHO AWaRe (Access, Watch, Reserve) classification of antibiotics
- WHO's own indication mapping is public — we align to it The WHO Antibiotics Portal lists amoxicillin as first choice for community-acquired pneumonia (mild to moderate), acute otitis media, acute sinusitis, acute pharyngitis and uncomplicated acute malnutrition in children; amoxicillin + clavulanic acid as first choice for severe community-acquired pneumonia in children, hospital-acquired pneumonia, cystitis and cellulitis; and ceftriaxone as first choice for severe acute pyelonephritis. WHO Antibiotics Portal — AWaRe
- AWaRe is the framework buyers and stewards now work to WHO's AWaRe classification divides antibiotics into Access, Watch and Reserve. Access agents are described as those that should be widely available, affordable and quality-assured to improve access and promote appropriate use. Watch agents carry higher resistance potential and should be prioritised as targets of stewardship programmes and monitoring. WHO Antibiotics Portal — AWaRe
We quote these sources rather than paraphrase them loosely, because the detail matters commercially for Amoxicillin Clavulanate 400/57mg Chewable Tablets. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.
Ordering Parameters for Amoxicillin Clavulanate 400/57mg Chewable Tablets
| Product Name | Amoxicillin/Clavulanate Chewable Tablets (Amoxicillin 400mg + Clavulanate 57mg Chewable Oral Tablets) |
| Specification | Each chewable tablet contains: Amoxicillin 400mg (as Amoxicillin Trihydrate) + Clavulanic Acid 57mg (as Clavulanate Potassium) |
| Dosage Form | Chewable Tablet (for oral administration; chew thoroughly before swallowing) |
| Active Ingredients | Amoxicillin / Clavulanic Acid (Clavulanate Potassium) |
| Pharmacological Class | Beta-Lactam Antibiotic + Beta-Lactamase Inhibitor Combination |
| Route of Administration | Oral administration (chew thoroughly before swallowing). May be taken with or without food. Taking with food may reduce gastrointestinal upset. |
| Storage | Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze. |
| Therapeutic group | Antibacterials — Antibacterials |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Ciprofloxacin 500mg Tablets, Amoxicillin Clavulanate 875/125mg Tablets, Amoxicillin Chewable Tablets 400mg, Azithromycin 500mg Tablets, Metronidazole Tablets 500mg, Ampicillin 500mg Capsules, Azithromycin 400mg Capsules, Clarithromycin 250mg Capsules.
Pharmacopoeial Standard, Release Testing & COA
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Every batch of Amoxicillin Clavulanate 400/57mg Chewable Tablets is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
The quality control package for the marketed pack covers:
- Testing for assay of the active substance
- Testing for related substances and impurities
- Testing for dissolution or release profile (solid oral forms)
- Testing for uniformity of dosage units
- Testing for water content and pH where applicable
- Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Packing, Labelling Languages & Export Paperwork
- Pack size: Blister pack (PVC-Alu) or HDPE bottle, typically 10 or 12 chewable tablets per blister pack or bottle. Non-standard pack sizes can be quoted against your artwork.
- Storage: Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze..
- Shelf life: 24 months (unopened). Stability data for the marketed pack is included in the dossier.
- Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
- Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.
Marketing Authorisation & Tender Support
Documents for Amoxicillin Clavulanate 400/57mg Chewable Tablets are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.
- Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
- Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
- Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
- Batch manufacturing and packaging records released for inspection on request during supplier audits.
- Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
The context for Amoxicillin Clavulanate 400/57mg Chewable Tablets is its place among antibacterials classified in the WHO AWaRe framework. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.
Amoxicillin Clavulanate 400/57mg Chewable Tablets: Common Procurement Questions
What pack size is available for Amoxicillin Clavulanate 400/57mg Chewable Tablets?
This presentation is normally supplied as Blister pack (PVC-Alu) or HDPE bottle, typically 10 or 12 chewable tablets per blister pack or bottle. Where your market requires a different count, bottle or carton, we quote to your artwork and extend the stability file to the new pack.
What documentation comes with a shipment of Amoxicillin Clavulanate 400/57mg Chewable Tablets?
Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 24 months.
Does the batch documentation for Amoxicillin Clavulanate 400/57mg Chewable Tablets support a registration filing?
Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 24 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
How do you handle stewardship restrictions?
Watch-group orders are supplied against documented purchase requirements. We can provide AWaRe classification reference material to support your tender or formulary documentation.
Which of your antibiotics are in the WHO Access group?
Amoxicillin, amoxicillin + clavulanic acid, ampicillin, clindamycin, gentamicin, metronidazole and chloramphenicol are classified in the Access group under the WHO AWaRe classification.
Products Commonly Ordered with Amoxicillin Clavulanate 400/57mg Chewable Tablets
- Ciprofloxacin 500mg Tablets — 500mg
- Amoxicillin Clavulanate 875/125mg Tablets — 875mg
- Amoxicillin Chewable Tablets 400mg — 400mg
- Azithromycin 500mg Tablets — 500mg
- Metronidazole Tablets 500mg — 500mg
- Ampicillin 500mg Capsules — 500mg
Browse the full Antibacterials range; all Tablets; the complete product catalogue.
Request a Quotation for Amoxicillin Clavulanate 400/57mg Chewable Tablets
For tenders and programme supply, send the line item, pack size, quantity and destination for Amoxicillin Clavulanate 400/57mg Chewable Tablets 400mg. We return a quotation with lead time, documentation list and sample availability in one response.
Sources & Regulatory Notes
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
